
CAS 1675248-18-6
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 Produkte.
1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)-
CAS:Formel:C18H25N5O3Reinheit:98%Farbe und Form:SolidMolekulargewicht:359.4228Ethyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
CAS:Ethyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoateReinheit:98%Molekulargewicht:359.42g/molEthyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
CAS:Reinheit:98%Molekulargewicht:359.429992675781252-Descyano-2-ethyl Formyl-tofacitinib
CAS:Kontrolliertes Produkt<p>Applications 2-Descyano-2-ethyl Formyl-tofacitinib is an impurity compound of Tofacitinib(C781351). Tofacitinib is a Janus kinase inhibitor for the treatment of rheumatoid arthritis.<br>References Sheiner, L., et al.: Clin. Pharmacol. Ther., 25, 358 (1979), Dayneka, N., et al.: J. Pharmacokin. Biopharm., 21, 457 (1993), Changelian, P., et al.: Science, 302, 875 (2003), Lee, H., et al.: Clin. Pharmacol. Ther., 73, 348 (2003), Hutmacher, M., et al.: J. Clin. Pharmacol., 47, 238 (2007),<br></p>Formel:C18H25N5O3Farbe und Form:NeatMolekulargewicht:359.423Ethyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
CAS:Please enquire for more information about Ethyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormel:C18H25N5O3Reinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:359.42 g/mol






